Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry

Por Yu, Jong-Han, Lee, Jong Won, Son, Byung Ho, Kim, Sung-Won, Park, Sue K., Lee, Min Hyuk, Kim, Lee Su, Noh, Woo-Chul, Kim, Eun-Kyu, Yoon, Dae Sung, Lee, Jeeyeon, Jung, Jin Hyang, Jung, Sang Seol, Gong, Gyungyup, Ahn, Sei-Hyun
Publicado em 2014

Novel mutations in the RING-finger domain of BRCA1 gene in clinically diagnosed breast cancer patients

Por Kumar, Pasupuleti Santhosh, Srikanth, Lokanathan, Reddy, K. Sudheer, Sarma, Potukuchi Venkata Gurunadha Krishna
Publicado no 3 Biotech (2020)

Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer‐predisposing gene

Por Bartkova, Jirina, Tommiska, Johanna, Oplustilova, Lenka, Aaltonen, Kirsimari, Tamminen, Anitta, Heikkinen, Tuomas, Mistrik, Martin, Aittomäki, Kristiina, Blomqvist, Carl, Heikkilä, Päivi, Lukas, Jiri, Nevanlinna, Heli, Bartek, Jiri
Publicado no Mol Oncol (2008)

PARP inhibitors are not all equal

Por Dent, Paul
Publicado em 2013

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

Por Toffoli, Sébastien, Bar, Isabelle, Abdel-Sater, Fadi, Delrée, Paul, Hilbert, Pascale, Cavallin, Frédéric, Moreau, Fabrice, Van Criekinge, Wim, Lacroix-Triki, Magali, Campone, Mario, Martin, Anne-Laure, Roché, Henri, Machiels, Jean-Pascal, Carrasco, Javier, Canon, Jean-Luc
Publicado no Breast Cancer Res (2014)

Interaction of BARD1 and HP1 is required for BRCA1 retention at sites of DNA damage

Por Wu, Wenwen, Nishikawa, Hiroyuki, Fukuda, Takayo, Vittal, Vinayak, Asano, Masahide, Miyoshi, Yasuo, Klevit, Rachel E., Ohta, Tomohiko
Publicado no Cancer Res (2015)

Genetic and epigenetic profiling of the BRCA1 / 2 genes in solitary ovarian cancer and multiple primary ovarian tumors

Por M. E. Esenova, Yu. G. Payanidi, S. V. Vinokurova, A. S. Shevchuk, M. N. Tikhonovskaya, K. I. Zhordania
Publicado em 2021-11-01

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness

Por Lips, Esther H, Laddach, Nadja, Savola, Suvi P, Vollebergh, Marieke A, Oonk, Anne MM, Imholz, Alex LT, Wessels, Lodewyk FA, Wesseling, Jelle, Nederlof, Petra M, Rodenhuis, Sjoerd
Publicado em 2011

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer

Por Bonanno, Laura, Costa, Carlota, Majem, Margarita, Sanchez, Jose-Javier, Rodriguez, Ignacio, Gimenez-Capitan, Ana, Molina-Vila, Miquel Angel, Vergnenegre, Alain, Massuti, Bartomeu, Favaretto, Adolfo, Rugge, Massimo, Pallares, Cinta, Taron, Miquel, Rosell, Rafael
Publicado no BMC Cancer (2016)

Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction

Por Subramanyam, Shyamal, Jones, William T., Spies, Maria, Spies, M. Ashley
Publicado em 2013

Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer

Por MOBASHERI, Maryam Beigom, SHIRKOOHI, Reza, MODARRESSI, Mohammad Hossein
Publicado no Iran J Public Health (2016)

The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland

Por Stacey, Simon N, Sulem, Patrick, Johannsson, Oskar T, Helgason, Agnar, Gudmundsson, Julius, Kostic, Jelena P, Kristjansson, Kristleifur, Jonsdottir, Thora, Sigurdsson, Helgi, Hrafnkelsson, Jon, Johannsson, Jakob, Sveinsson, Thorarinn, Myrdal, Gardar, Grimsson, Hlynur Niels, Bergthorsson, Jon T, Amundadottir, Laufey T, Gulcher, Jeffrey R, Thorsteinsdottir, Unnur, Kong, Augustine, Stefansson, Kari
Publicado em 2006

An Integrative Omics Approach Reveals Involvement of <i>BRCA1</i> in Hepatic Metastatic Progression of Colorectal Cancer

Por Daniela Gerovska, Gorka Larrinaga, Jon Danel Solano-Iturria, Joana Márquez, Patricia García Gallastegi, Abdel-Majid Khatib, Gereon Poschmann, Kai Stühler, María Armesto, Charles H. Lawrie, Iker Badiola, Marcos J. Araúzo-Bravo
Publicado em 2020-08-01

Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer

Por Hińcza, Kinga, Kowalik, Artur, Kowalska, Aldona
Publicado no Genes (Basel) (2019)

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing

Por Lu, Hsiao-Mei, Li, Shuwei, Black, Mary Helen, Lee, Shela, Hoiness, Robert, Wu, Sitao, Mu, Wenbo, Huether, Robert, Chen, Jefferey, Sridhar, Srijani, Tian, Yuan, McFarland, Rachel, Dolinsky, Jill, Tippin Davis, Brigette, Mexal, Sharon, Dunlop, Charles, Elliott, Aaron
Publicado no JAMA Oncol (2018)

Genetic risk prediction in complex disease

Por Jostins, Luke, Barrett, Jeffrey C.
Publicado em 2011

Current advances in biomarkers for targeted therapy in triple-negative breast cancer

Por Fleisher, Brett, Clarke, Charlotte, Ait-Oudhia, Sihem
Publicado no Breast Cancer (Dove Med Press) (2016)

The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study

Por Guerini-Rocco, Elena, Hodi, Zsolt, Piscuoglio, Salvatore, Ng, Charlotte KY, Rakha, Emad A, Schultheis, Anne M, Marchiò, Caterina, Paula, Arnaud da Cruz, De Filippo, Maria R, Martelotto, Luciano G, De Mattos-Arruda, Leticia, Edelweiss, Marcia, Jungbluth, Achim A, Fusco, Nicola, Norton, Larry, Weigelt, Britta, Ellis, Ian O, Reis-Filho, Jorge S
Publicado no J Pathol (2015)

Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation

Por Ashraf, Zaman, Mahmood, Tariq, Hassan, Mubashir, Afzal, Samina, Rafique, Hummera, Afzal, Khurram, Latip, Jalifah
Publicado no Drug Des Devel Ther (2019)

The Nipple-Areola Preserving Mastectomy: A Multistage Procedure Aiming to Improve Reconstructive Outcomes following Mastectomy

Por Martinez, Carlos A., Reis, Scott M., Sato, Erika A., Boutros, Sean G.
Publicado no Plast Reconstr Surg Glob Open (2015)